文献速递神经儿科影像MR

儿童高级别胶质瘤中错配修复缺陷综合征的脑MRI特异性表现

Specific brain MRI features of constitutional mismatch repair deficiency syndrome in children with high-grade gliomas.
PubMed 文献 · Eur Radiol · 2024-07-09

本研究回顾性比较了30例CMMRD患儿(22例伴高级别胶质瘤)与Lynch综合征、NF1及无易感因素高级别胶质瘤患儿的脑影像,发现CMMRD相关高级别胶质瘤多位于大脑半球且边界不清,全部CMMRD患儿至少存在一处发育性静脉异常(DVA),多发DVA、海绵状血管瘤及NF1样或皮层下T2-FLAIR高信号灶更常见,提示这些影像特征可提示CMMRD综合征并可能促成基因检测。

要点

  • 儿童高级别胶质瘤位于大脑半球且伴多发DVA时,应高度怀疑CMMRD综合征。
  • 全部CMMRD患儿至少见一处DVA,83%为多发DVA,海绵状血管瘤见于21%。
  • CMMRD患儿中50%见NF1样T2-FLAIR高信号灶,皮层下边界不清者具特异性。

核心结论

  • 弥漫性大脑半球分布的高级别胶质瘤伴多发DVA、海绵状血管瘤及NF1样或皮层下T2-FLAIR高信号灶,与其他情境下的儿童高级别胶质瘤相比强烈提示CMMRD综合征。

研究设计与样本

  • 回顾性比较分析脑影像,纳入30例CMMRD患儿(20例男孩,中位年龄8岁,22例伴高级别胶质瘤)、7例Lynch综合征(均伴高级别胶质瘤)、39例1型神经纤维瘤病(NF1,4例伴高级别胶质瘤)及50例无MMR或NF1致病性变异的高级别胶质瘤患儿。

关键影像表现/征象

  • CMMRD与Lynch综合征患者的高级别胶质瘤以大脑半球为主(分别91%和86%),NF1与无易感因素患者分别为25%和54%(p=0.004)。
  • CMMRD相关肿瘤常边界不清(p=0.008)。
  • 全部CMMRD患者至少见一处DVA,Lynch、NF1及无易感因素患者分别为14%、10%和6%(p<0.0001)。
  • 多发DVA见于83%的CMMRD患者、1例NF1患者(3%),其他组未见(p<0.0001)。
  • 海绵状血管瘤见于21%的CMMRD患者,其他组未见(p=0.01)。

诊断标准与关键数值

  • 全部CMMRD患者至少见一处DVA,Lynch、NF1及无易感因素患者分别为14%、10%和6%(p<0.0001)。
  • 多发DVA见于83%的CMMRD患者、1例NF1患者(3%),其他组未见(p<0.0001)。
  • 海绵状血管瘤见于21%的CMMRD患者,其他组未见(p=0.01)。
  • NF1样T2-FLAIR高信号灶(FASI)见于50%的CMMRD患者,Lynch及无易感因素患者分别为20%和0%(p<0.0001)。
  • 皮层下及边界不清、可能累及皮层的FASI为CMMRD特异(p<0.0001),93%(13/14)患者未见演变。

临床应用与阅片要点

  • 面对儿童高级别胶质瘤时,若见大脑半球分布、边界不清并伴多发DVA、海绵状血管瘤或NF1样/皮层下FASI,影像上可提示CMMRD综合征并可能促成基因检测。
  • 作者提出新的影像特征以改进对潜在CMMRD患者的识别。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Children with constitutional mismatch repair deficiency (CMMRD) syndrome have an increased risk of high-grade gliomas (HGG), and brain imaging abnormalities. This study analyzes brain imaging features in CMMRD syndrome children versus those with HGG without CMMRD.

METHODS: Retrospective comparative analysis of brain imaging in 30 CMMRD children (20 boys, median age eight years, 22 with HGG), seven with Lynch syndrome (7 HGG), 39 with type 1 neurofibromatosis (NF1) (four with HGG) and 50 with HGG without MMR or NF1 pathogenic variant ("no-predisposition" patients).

RESULTS: HGG in CMMRD and Lynch patients were predominantly hemispheric (versus midline) compared to NF1 and no-predisposition patients (91% and 86%, vs 25% and 54%, p = 0.004). CMMRD-associated tumors often had ill-defined boundaries (p = 0.008). All CMMRD patients exhibited at least one developmental venous anomaly (DVA), versus 14%, 10%, and 6% of Lynch, NF1, and no-predisposition patients (p < 0.0001). Multiple DVAs were observed in 83% of CMMRD patients, one NF1 patient (3%), and never in other groups (p < 0.0001). Cavernomas were discovered in 21% of CMMRD patients, never in other groups (p = 0.01). NF1-like focal areas of high T2-FLAIR signal intensity (FASI) were more prevalent in CMMRD patients than in Lynch or no-predisposition patients (50%, vs 20% and 0%, respectively, p < 0.0001). Subcortical and ill-limited FASI, possibly involving the cortex, were specific to CMMRD (p < 0.0001) and did not evolve in 93% of patients (13/14).

CONCLUSION: Diffuse hemispherically located HGG associated with multiple DVAs, cavernomas, and NF1-like or subcortical FASI strongly suggests CMMRD syndrome compared to children with HGG in other contexts.

CLINICAL RELEVANCE STATEMENT: The radiologic suggestion of CMMRD syndrome when confronted with HGGs in children may prompt genetic testing. This can influence therapeutic plans. Therefore, imaging features could potentially be incorporated into CMMRD testing recommendations.

KEY POINTS: Using imaging to detect CMMRD syndrome early may improve patient care. CMMRD features include: hemispheric HGG with multiple developmental venous anomalies and NF1-like or subcortical areas with high T2-FLAIR intensity. We propose novel imaging features to improve the identification of potential CMMRD patients.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Raveneau M, Guerrini-Rousseau L, Levy R, et al. Specific brain MRI features of constitutional mismatch repair deficiency syndrome in children with high-grade gliomas. Eur Radiol. 2024. PMID: 38981890. doi:10.1007/s00330-024-10885-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。